Agilent Technologies, Inc. (A)

Market Cap	32.44B +8.1%
Revenue (ttm)	7.07B +8.1%
Net Income	1.29B +2.5%
EPS	4.53 +3.9%
Shares Out	282.60M
PE Ratio	25.11
Forward PE	18.56
Dividend	$1.02 (0.89%)
Ex-Dividend Date	Mar 31, 2026

Volume	2,416,761
Open	112.59
Previous Close	113.78
Day's Range	111.06 - 114.83
52-Week Range	107.07 - 160.27
Beta	1.22
Analysts	Buy
Price Target	161.07 (+40.32%)
Earnings Date	May 27, 2026

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 18, 1999
• Employees: 18,100
• Stock Exchange: NYSE
• Ticker Symbol: A
• Website: https://www.agilent.com

Financial Performance

In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.

Analyst Summary

According to 17 analysts, the average rating for A stock is "Buy." The 12-month stock price target is $161.07, which is an increase of 40.32% from the latest price.

Price Target

$161.07

(40.32% upside)

Analyst Consensus: Buy